Status: Recruiting
MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder
This randomized, double-blind, single-site phase II 2-arm study will investigate the safety and preliminary efficacy of MDMA-assisted therapy compared with low dose d-amphetamine-assisted therapy on the severity of PTSD symptoms in participants aged 18 years and older with PTSD of at least moderate severity.
Participants needed: 40
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Stephen Robert MarderUpdated: Aug 19, 2026Locations: 2
Eligibility criteria
At Screening, meet DSM-5 criteria for current PTSD with a symptom duration of at... [+10]
Are not able to give adequate informed consent. [+4]